316 related articles for article (PubMed ID: 31928220)
21. Dexmedetomidine inhibits LPS-induced inflammatory responses through peroxisome proliferator-activated receptor gamma (PPARγ) activation following binding to α
Fujimoto M; Higuchi H; Honda-Wakasugi Y; Miyake S; Nishioka Y; Yabuki-Kawase A; Maeda S; Miyawaki T
Eur J Pharmacol; 2021 Feb; 892():173733. PubMed ID: 33220278
[TBL] [Abstract][Full Text] [Related]
22. The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study.
Buttar NS; Wang KK; Anderson MA; Dierkhising RA; Pacifico RJ; Krishnadath KK; Lutzke LS
J Natl Cancer Inst; 2002 Mar; 94(6):422-9. PubMed ID: 11904314
[TBL] [Abstract][Full Text] [Related]
23. Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats.
Zhao Y; Patzer A; Herdegen T; Gohlke P; Culman J
FASEB J; 2006 Jun; 20(8):1162-75. PubMed ID: 16770015
[TBL] [Abstract][Full Text] [Related]
24. Pioglitazone, a Specific Ligand of the Peroxisome Proliferator-Activated Receptor Gamma Reduces Gastric Mucosal Injury Induced by Ischaemia/Reperfusion in Rat.
Konturek PC; Brzozowski T; Kania J; Kukharsky V; Bazela K; Kwiecien S; Harsch I; Konturek SJ; Hahn EG
Scand J Gastroenterol; 2003; 38(5):468-476. PubMed ID: 28443766
[TBL] [Abstract][Full Text] [Related]
25. Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation.
Ogunwobi O; Mutungi G; Beales IL
Endocrinology; 2006 Sep; 147(9):4505-16. PubMed ID: 16740977
[TBL] [Abstract][Full Text] [Related]
26. Characterization of acid and alkaline reflux in patients with Barrett's esophagus. G.O.S.P.E. Operative Group for the study of Esophageal Precancer.
D'Onofrio V; Bovero E; Iaquinto G
Dis Esophagus; 1997 Jan; 10(1):16-22; discussion 22-3. PubMed ID: 9079268
[TBL] [Abstract][Full Text] [Related]
27. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
28. Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett's esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants.
Lee JS; Oh TY; Ahn BO; Cho H; Kim WB; Kim YB; Surh YJ; Kim HJ; Hahm KB
Mutat Res; 2001 Sep; 480-481():189-200. PubMed ID: 11506813
[TBL] [Abstract][Full Text] [Related]
29. Gastric ulcer healing and stress-lesion preventive properties of pioglitazone are attenuated in diabetic rats.
Konturek PC; Brzozowski T; Burnat G; Szlachcic A; Koziel J; Kwiecien S; Konturek SJ; Harsch IA
J Physiol Pharmacol; 2010 Aug; 61(4):429-36. PubMed ID: 20814070
[TBL] [Abstract][Full Text] [Related]
30. Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett's esophagus to adenocarcinoma.
Li Y; Wo JM; Ray MB; Jones W; Su RR; Ellis S; Martin RC
World J Gastroenterol; 2006 Feb; 12(6):928-34. PubMed ID: 16521222
[TBL] [Abstract][Full Text] [Related]
31. Phenotype of columnar-lined esophagus in rats with esophagogastroduodenal anastomosis: similarity to human Barrett's esophagus.
Su Y; Chen X; Klein M; Fang M; Wang S; Yang CS; Goyal RK
Lab Invest; 2004 Jun; 84(6):753-65. PubMed ID: 15094711
[TBL] [Abstract][Full Text] [Related]
32. Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line.
Konturek PC; Burnat G; Rau T; Hahn EG; Konturek S
Dig Dis Sci; 2008 Mar; 53(3):597-605. PubMed ID: 17763959
[TBL] [Abstract][Full Text] [Related]
33. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
[TBL] [Abstract][Full Text] [Related]
34. Effect of Helicobacter pylori infection on Barrett's esophagus and esophageal adenocarcinoma formation in a rat model of chronic gastroesophageal reflux.
Liu FX; Wang WH; Wang J; Li J; Gao PP
Helicobacter; 2011 Feb; 16(1):66-77. PubMed ID: 21241415
[TBL] [Abstract][Full Text] [Related]
35. COX-2 inhibition in esophagitis, Barrett's esophagus and esophageal cancer.
Piazuelo E; Jimenez P; Lanas A
Curr Pharm Des; 2003; 9(27):2267-80. PubMed ID: 14552327
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of transforming growth factor-alpha and epidermal growth factor receptors in rat chronic reflux esophagitis.
Fujiwara Y; Higuchi K; Hamaguchi M; Takashima T; Watanabe T; Tominaga K; Oshitani N; Matsumoto T; Arakawa T
J Gastroenterol Hepatol; 2004 May; 19(5):521-7. PubMed ID: 15086595
[TBL] [Abstract][Full Text] [Related]
37. Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus.
Kaur BS; Khamnehei N; Iravani M; Namburu SS; Lin O; Triadafilopoulos G
Gastroenterology; 2002 Jul; 123(1):60-7. PubMed ID: 12105834
[TBL] [Abstract][Full Text] [Related]
38. Potentiation of indomethacin-induced anti-inflammatory response by pioglitazone in carrageenan-induced acute inflammation in rats: Role of PPARγ receptors.
Houshmand G; Mansouri MT; Naghizadeh B; Hemmati AA; Hashemitabar M
Int Immunopharmacol; 2016 Sep; 38():434-42. PubMed ID: 27376854
[TBL] [Abstract][Full Text] [Related]
39. [Chemoprevention of Barrett's esophagus by celecoxib in rats].
Wang RH; Ou-Yang Q; Chen X; Li GD; Xiang JY
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 38(5):498-504. PubMed ID: 19830863
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis.
Jankowski J; Hopwood D; Pringle R; Wormsley KG
Am J Gastroenterol; 1993 Mar; 88(3):402-8. PubMed ID: 8438848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
